| HOME >> BIOLOGY >> TECHNOLOGY |
A generally accepted 44-year-old assumption about how certain kinds of bacteria make energy and synthesize cell materials has been shown to be incorrect by a team of scientists led by Donald Bryant, the Ernest C. Pollard Professor of Biotechnology at Penn State University and a research professor in the Department of Chemistry and Biochemistry at Montana State University. The research, which will be published in the journal Science on 16 December 2011, is expected to help scientists discover new ways of genetically engineering bacteria to manufacture biofuels -- energy-rich compounds derived from biological sources. Many textbooks, which cite the 44-year-old interpretation as fact, likely will be revised as a result of the new discovery.
Bryant explained that, in 1967, two groups of researchers concluded that an important energy-making cycle was incomplete in cyanobacteria -- photosynthetic bacteria formerly known as blue-green algae. This energy-producing cycle -- known as the tricarboxylic acid (TCA) cycle or the Krebs cycle -- includes a series of chemical reactions that are used for metabolism by most forms of life, including bacteria, molds, protozoa, and animals. This series of chemical reactions eventually leads to the production of ATP -- molecules responsible for providing energy for cell metabolism. "During studies 44 years ago, researchers concluded that cyanobacteria were missing an essential enzyme of the metabolic pathway that is found in most other life forms," Bryant explained. "They concluded that cyanobacteria lacked the ability to make one enzyme, called 2-oxoglutarate dehydrogenase, and that this missing enzyme rendered the bacteria unable to produce a compound -- called succinyl-coenzyme A -- for the next step in the TCA cycle. The absence of this reaction was assumed to render the organisms unable to oxidize metabolites for energy production, although they could still use the remaining TCA-cycle reactions to produce substra
'/>"/>
| Contact: Barbara Kennedy science@psu.edu 814-863-4682 Penn State Source:Eurekalert |
Related biology technology :
1. YM BioSciences announces conclusion of Phase I dose-escalation and expansion of ongoing CYT387 Phase I/II clinical study
2. Video: Moms Raise Red Flag About the Dangers of Widely Undiagnosed Bleeding Disorder
3. Swedish Neuroscience Institute and Institute for Systems Biology in Seattle Form Alliance to Learn More about Brain Diseases
4. New knowledge about thermoelectric materials could give better energy efficiency
5. 25 Short Films About Top-Level Research on swissinfo.ch
6. BioIQ Supports American Heart Month to Raise Awareness About Heart Disease, the #1 Killer of Women
7. Nature Reviews Publishes Article About Jennerexs Multi-Mechanistic Cancer Therapeutic
8. The Coalition to Prevent Deep-Vein Thrombosis (DVT) RV Tour Takes to the Road to Educate the Nation About the Importance of DVT Risk Assessment
9. Repair Stem Cell Institute Warns About Real Cost of Embryonic Stem Cell Research
10. American Medical Informatics Association (AMIA) Submits Comments to Hit Policy Committee About Meaningful Use and Electronic Health Record Certification
11. American Mothers Seriously Concerned About Childhood Allergies, Siemens Survey Reveals
 |
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |